Stock Updates

Today’s Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining 1.14% today. In the last week its performance is 5.54%, and -3.76% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 468.14, so today’s gain of 1.14% is a significant step towards its target price. The GAP today is therefore 0.40%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 39501, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 71.30%.

At the current price of 389.07, it has a dividend yield of *TBA, and its target price is 468.14. This is with a profit margin of 16.40%, and total debt/equity of 0.1. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 61.09, as well as a forward P/E of 25.13.

With a current EPS of 6.3, and a forecasted EPS growth for next year at 41.75%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 44.90%. For the next five years EPS growth is projected to be 19.09%.

Performance for the year is -31.30%. Since its IPO date on 4/2/1991, the total performance to date is -29.14%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 557529, while its average volume is 893.78. Whilst the total gain today was 1.14%, it did have a day high of -4.72%.

Volatility for this week has been at 2.74%, and 2.87% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 18.23%, while the 52-week-high has reached -35.79%.

Looking at its return of investments, which is 16.00%, and its return on assets is 13.70%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 28.90%. With a sales growth of 38.10% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.1, and has a current ratio of 3.4 and 3.1 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3.2, and the P/S is 8.91, along with a P/B of 10.66. Meanwhile it has a p/cash of 46.52.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment